跳至主要内容
临床试验/NCT06110754
NCT06110754已完成不适用

Integrative Training Program for Pediatric Sickle Cell Pain (I-STRONG for SCD): Optimizing Feasibility and Acceptability

Emory University4 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2023年6月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
4
主要终点
Brief Pain Inventory (BPI) Pain Severity Score

研究概览

简要总结

This study develops and tests the feasibility and acceptability of an adapted intervention, Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle cell disease.

详细描述

Pain is the hallmark feature of sickle cell disease (SCD), a life-limiting chronic illness that disproportionately affects African Americans. Well-documented racial disparities complicate effective pain control and the under-treatment of pain experienced by Black Americans with SCD. Approximately 20% of youth with SCD develop chronic pain and experience significant functional impairment, diminished quality of life, and comorbid depression and anxiety that can worsen over time. Youth with chronic SCD pain often are stuck in a vicious cycle of pain, functional impairment, and pain-related fear of movement that contributes to activity avoidance and exacerbates pain. The most effective chronic SCD pain management requires multicomponent, interdisciplinary treatment approaches that include integrative mind-body treatments. Mind-body approaches, specifically diaphragmatic breathing, progressive muscle relaxation, and guided imagery, can improve outcomes for youth with chronic pain. However, multicomponent interventions tailored for chronic SCD pain have never been established. Most pain interventions are developed and studied largely with white youth, do not address cultural influences, and consequently have limited generalizability for minoritized populations that experience health disparities like SCD. There is a critical need for effective, culturally tailored, integrative pain management approaches to address health disparities and improve outcomes for youth with SCD whose chronic pain can persist into adulthood.

To address this unmet need, the researchers will leverage an existing innovative intervention designed for juvenile fibromyalgia, the Fibromyalgia Integrative Training for Teens (FIT Teens). Recent clinical practice guidelines for SCD pain identified fibromyalgia as most closely aligned with chronic pain in SCD to inform treatment recommendations; thus, FIT Teens is well-suited for adaptation and testing for SCD. FIT Teens is an 8-week (16 session) group-based telehealth intervention that combines mind-body, cognitive-behavioral, and neuromuscular movement approaches. Early trials of FIT Teens found excellent patient engagement, and medium to large effects on reducing disability, pain, depressive symptoms, and fear of movement without adverse effects of pain exacerbation. An ongoing multicenter trial of FIT Teens has excellent patient retention (>80%, n=300 enrolled). The mind-body, cognitive-behavioral, and neuromuscular movement treatment components will form the basis of a new multicomponent integrative intervention tailored for SCD.

Aim 1 of this study is to adapt and refine the integrative components of the FIT Teens intervention to develop a new culturally tailored I-STRONG intervention for youth with chronic SCD pain. The investigators will conduct mixed method approaches and purposive sampling to collect qualitative feedback informed by patient and family lived experiences regarding intervention content, format, perceived benefits, and barriers/facilitators to engagement from 15 patients (12 to 18 years of age) with chronic SCD pain and their parents and about 8 adolescents and 8 parents to participate in stakeholder advisory boards. Community stakeholder advisory boards and iterative design will inform intervention adaptation and refinement to enhance clinical implementation. Outcome measures are not collected from participants in Aim 1 as the purpose of this part of the study is to prepare the I-STRONG intervention to be studied for Aim 2.

Aim 2 of the study is to assess feasibility and acceptability of I-STRONG intervention for youth with chronic SCD pain. The investigators will conduct a single-arm proof-of-concept study of the I-STRONG intervention with 12 adolescents (12 to 18 years of age), and the parents of adolescents under the age of 18, to iteratively optimize the feasibility and acceptability of I-STRONG in youth with chronic SCD pain. Feasibility will be demonstrated by rates of study enrollment, retention, and adherence (target goals set at ≥ 75%). Acceptability will be demonstrated by treatment burden, satisfaction, and tolerability. Qualitative feedback about the program format and content will inform additional intervention optimization, refinement, and enhance feasibility and acceptability.

Support from and inclusion in the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (HEAL), or NIH HEAL Initiative, is provided for this study. For more information about the initiative visit the HEAL Initiative (https://heal.nih.gov/).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosed with SCD (any genotype)
  • •Score of at least 3 (indicating medium to high risk for chronic pain) on the Pediatric Pain Screening Tool
  • •Stable disease-modifying treatments, if applicable, as defined by no newly initiated or significantly increased dosages (mg/kg) in the past 3 months (Aim 2 only)
  • •English fluency (Aim 2 only)

排除标准

  • •Comorbid medical conditions typically associated with pain but unrelated to SCD (e.g., rheumatologic disorders or inflammatory bowel disease)
  • •Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation (e.g., severe avascular necrosis with limited or non-weight bearing restrictions, significant cognitive or developmental limitations, active suicidal ideation) (Aim 2 only)
  • •Adolescent receiving active treatment (e.g., weekly appointments with a provider) for nonpharmacological therapies (e.g, structured behavioral pain management, physical therapy, or acupuncture program) that overlap with the active phase of the study intervention (Aim 2 only)

研究组 & 干预措施

Development of I-STRONG for SCD

No Intervention

Adolescents with sickle cell disease and their parents participating completing in-depth interviews over two sessions as part of adapting an integrative, multicomponent, behavioral intervention combining mind-body, cognitive, and behavioral coping skills with neuromuscular exercise training for adolescents with chronic SCD pain.

I-STRONG for SCD

Experimental

Adolescents with sickle cell disease and their parents participating in a multi-component intervention that includes mind-body, cognitive-behavioral, and neuromuscular movement training.

干预措施: I-STRONG for SCD (Behavioral)

结局指标

主要结局

Brief Pain Inventory (BPI) Pain Severity Score

时间窗: Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)

Pain intensity is rated with the pain severity item of the Brief Pain Inventory (BPI). The single item is scored on a scale from 0 to 10 where no pain = 0 and severe pain = 10.

次要结局

  • Brief Pain Inventory (BPI) Pain Interference Score(Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • Patient Health Questionnaire (PHQ-8) Score(Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • General Anxiety Disorder (GAD-2) Score(Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • Pain Catastrophizing Scale Score(Baseline, Post-treatment (Week 8), 3 Months Post-Treatment (Month 5))
  • Pediatric Quality of Life Inventory (PedsQL) Score(Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • Adolescent Sleep-Wake Scale (ASWS) Score(Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • National Institute on Drug Abuse (NIDA)-Modified ASSIST (NM ASSIST) Tool Level 2(Baseline, 3 Months Post-treatment (Month 5))
  • Days of Opioid Use Per Week(Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • Change in Patient Global Impression of Change (PGIC) Score(Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • Treatment Evaluation Inventory-Short Form (TEI-SF) Score(Post-treatment (Week 8), 3 Months Post-treatment (Month 5))
  • Tampa Scale of Kinesiophobia (TSK) Score(Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soumitri Sil

Associate Professor

Emory University

研究点 (4)

Loading locations...

相似试验